Skip to main content

Nasdaq News

Why Bed Bath & Beyond Stock Is Up

6 years 1 month ago
In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Jim Gillies about the latest headlines and earning reports from Wall Street. They've got the turnaround story of Bed Bath & Beyond (NASDAQ: BBBY), they go through the sales report of a food and bever

Fibrosis biotech Galecto files for a $100 million IPO

6 years 1 month ago
Galecto, a Phase 2 biotech developing therapeutics for fibrosis and fibrotic related diseases, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. Galecto's initial focus is on the development of small-molecule inhibitors of galectin-3&
Checked
23 minutes 28 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed